Teva's collapse - Israel's biotech recovery
Over the past two years, Teva lost $57b. of value, leaving it with a remaining market value of $19b.
from Biotech News
Over the past two years, Teva lost $57b. of value, leaving it with a remaining market value of $19b.
The most important thing is to improve and not stop. Even if you have taken some course, this does not mean that you are now a guru. You need to constantly practice, learn something new.
0 Comments